encyclopedia of medical concepts
ψ
ψ

3,4-diaminopyridine

under 4-Aminopyridine
More information in Books or onNLM PubMed
More on 4-Aminopyridine Definition: One of the POTASSIUM CHANNEL BLOCKERS, with secondary effect on calcium currents, which is used mainly as a research tool and to characterize channel subtypes.      Other names VMI103; VMI 103; Sustained Release, 4-Aminopyridine; Fampridine SR; 4 Aminopyridine Sustained Release; 4 Aminopyridine; VMI-103; Pymadine; Fampridine-SR; 4-Aminopyridine Sustained Release
SubstanceCAS Registry & nameCategoriesSourceDrugs*
3,4-diaminopyridine
  potassium channel blocker in membranes 		54-96-6   4-Aminopyridine/*analogs & derivatives Potassium Channels
Pharma Action Potassium Channel Blockers 		Biophys J 22(3):507;1978; Clin Exp Pharmacol Physiol 6(2):159;1979; Eur J Pharmacol 1980;61(1):25; J Pharm Pharm 30(4):249;1978

To share this definition, click "text" (Facebook, Twitter) or "link" (blog, mail) then paste text link
Ads by Google

Sources: NLM Medical Subject Headings, NIH UMLS, Drugs@FDA, FDA AERS original data copyright United States Government. No endorsement implied. Last modified 6/6/2012
Warning: the drugs or drug combinations referred to here may be similar or related, but are not be the same ones and may not have the same pharmacological action as other substances described on the same page or in the same row. Please refer to product monograph or to your doctor
This website is accredited by Health On the Net Foundation. Click to verify. We comply with the HONcode standard for trustworthy health information: verify here.
About Reference.MD Privacy